Today: 9 April 2026

Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Update: New AI Chip News Sparks Bull-Bear Battle for $AAPL

Apple stock traded around $247 on Oct. 16, down nearly 1% from the previous close. Shares briefly rallied after Apple launched M5 chip-based MacBook Pro, iPad Pro, and Vision Pro Gen2 on Oct. 15, but slipped as profit-taking hit tech stocks. Wall Street targets range widely, with Wedbush at $310 and Jefferies at $205. Apple’s Q3 revenue rose 10% to $94 billion, beating estimates.
16 October 2025
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet (GOOGL) Stock Skyrockets on AI & Ad Revival – Could $300 Be Next?

Alphabet traded near $256 on Oct. 16, up 2% and close to record highs, putting its market value near $3 trillion. Scotiabank raised its price target to $310, citing a recovery in Google’s ad business, while BMO Capital lifted its target to $294 on AI gains. Google Cloud revenue rose 32% in Q2 to $13.6 billion. YouTube ad revenue jumped 13% to $9.8 billion, beating forecasts.
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock’s Wild Ride: Soars on Record Deliveries, Then Sags After Budget EV Reveal

Tesla reported 497,099 Q3 deliveries, beating forecasts by over 50,000 units as buyers rushed to claim expiring U.S. tax credits. TSLA shares swung sharply, surging 5% on Oct 13 before slipping 1.5% Oct 14, and traded near $430 midday Oct 16. New lower-priced Model Y and 3 trims failed to impress investors. Wall Street remains split; HSBC holds a $127 target, far below current levels.
Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar became the first Ukrainian company to list on Nasdaq on August 15, 2025, raising $178 million and debuting near $14 per share. After dropping to $11.25 by mid-September, the stock rebounded to $14.06 on October 16 following announcements of a $1 billion network upgrade and a Mastercard partnership. Four analysts rate KYIV a “Strong Buy” with an average price target of $17.08.
16 October 2025
Plug Power Stock Explodes 170% on Analyst Hype & Giant Hydrogen Deal

Plug Power (PLUG) Stock Skyrockets on Hydrogen Hype – Is PLUG a Buy or Bubble?

PLUG shares closed at $3.85 on Oct. 15, down 4.8% after doubling since early September. The company delivered a 10 MW electrolyzer to Galp Energy in Portugal on Oct. 1, part of Europe’s largest PEM project. Plug named Jose Luis Crespo as incoming CEO, prompting a 3% pre-market drop on Oct. 7. Q2 revenue rose 21% to $174 million, but the firm posted a $0.16 per-share loss.
16 October 2025
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Skyrockets on $100B AI Deal – Will NVDA Hit $320 Target?

Nvidia closed at $184.87 on Oct. 15, up about 30% year-to-date and far ahead of the S&P 500. The company announced a $100 billion AI deal with OpenAI and a $5 billion investment in Intel. Q2 FY2026 revenue jumped 56% to $46.7 billion, driven by data-center sales. U.S. regulators approved new Nvidia chip exports, while China increased scrutiny and opened an antitrust probe.
Billionaire-Backed Crypto Bank Approved by Regulators – Are Tech Stocks and Crypto Ready to Soar?

Billionaire-Backed Crypto Bank Approved by Regulators – Are Tech Stocks and Crypto Ready to Soar?

The OCC granted preliminary approval for Erebor Bank, a crypto-focused startup backed by Palmer Luckey, Joe Lonsdale, and Founders Fund, marking the first new national bank charter under Comptroller Jonathan Gould. Erebor must secure FDIC insurance and meet strict capital and compliance requirements before opening. The S&P 500 rose 0.4% and Bitcoin traded near $111,000 after the news.
Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

Oracle shares traded near $304 on Oct. 16, 2025, up sharply year-to-date after securing major AI cloud contracts, including a reported $300 billion deal with OpenAI. Q1 FY2026 revenue rose 12% to $14.93 billion. CEO Safra Catz will step down, with Clay Magouyrk and Mike Sicilia named co-CEOs. Wall Street targets cluster in the low-to-mid $300s, though some analysts warn of high valuation risks.
Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Western Alliance shares fell about 4% on Oct 8 and stayed down 5–6% by Oct 16 after news of exposure to bankrupt First Brands Group, which owes $10–$50 billion. A Jefferies fund held $715 million in First Brands receivables, raising fears of losses. Analysts maintain a Strong Buy consensus with a $103 average target. Q3 earnings are due Oct 21, with estimates at $2.11 EPS on $891 million revenue.
16 October 2025
Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

SCNX shares jumped over 30% in early trading Oct. 16 after Scienture announced Arbli, the first FDA-approved ready-to-use liquid losartan, is now available through major wholesalers. The stock hit an intraday high of $1.12 before trading near $0.71 by mid-day. Scienture recently secured a major rebate deal to drive Arbli’s adoption. Analysts remain cautious, citing weak financials and high volatility.
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL shares jumped 13.6% to close at $85.82 on Oct. 16 after announcing a $110 million equity investment and distribution deal with Samsung C&T and Samsung Electronics. Samsung C&T will exclusively distribute GRAIL’s Galleri cancer test in South Korea, with possible expansion to Japan and Singapore. GRAL’s market cap rose to about $2.7 billion. Most analysts maintain a Hold rating despite the stock’s 321% year-to-date gain.
Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk shares surged as much as 67% on Oct. 16 after announcing a multi-year collaboration with Tempus to use AI and real-world patient data in cancer drug development. The stock traded above $3.00 early Wednesday, up from a $2.10 close the previous day. Whitehawk plans to file INDs for its lead antibody-drug conjugates by late 2025. The company reported $177.2 million in cash at the end of June.
16 October 2025
Polestar Stock Skyrockets on Strong EV Sales and New Tech – What’s Next?

Polestar Stock Skyrockets on Strong EV Sales and New Tech – What’s Next?

Polestar reported Q3 2025 retail EV sales of 14,192, up 13% year-over-year, pushing year-to-date sales to 44,482. Shares (PSNY) traded near $0.94 on Oct. 16, up about 3% for the week, while warrants (PSNYW) surged 76% intraday on heavy volume. Analysts remain cautious, with a consensus “Reduce” rating and a $1.25 price target. The company launched new tech and confirmed future models amid strong global EV demand.
United Airlines Stock Takes Off on Travel Boom and Record Revenue Forecast

United Airlines Stock Takes Off on Travel Boom and Record Revenue Forecast

United Airlines shares rose from about $99 to $104 between Oct. 13 and Oct. 15 after reporting Q3 adjusted earnings of $2.78 per share, beating estimates. The company raised its Q4 guidance, forecasting adjusted earnings of $3.00–$3.50 per share. Revenue for Q3 reached $15.2 billion, just below analyst expectations. United announced new European routes for summer 2026 and resumed contract talks with flight attendants.
16 October 2025
Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna shares rose 5% to $28 but remain down 35% in 2024 and nearly 80% below last year’s level. COVID vaccine sales have collapsed from $18.9 billion in 2022 to $3.1 billion, and Q2 revenue fell 41% to $142 million. The company cut its 2025 revenue forecast and is laying off 10% of staff. Early data from an experimental cancer vaccine showed a 24% tumor response rate in advanced melanoma.
Kelly Services’ Tech-Driven Hiring Triumphs Spark Stock Rally Hopes

Kelly Services’ Tech-Driven Hiring Triumphs Spark Stock Rally Hopes

Kelly Services became the first firm named both “Leader” and “Star Performer” in all categories of Everest Group’s 2025 U.S. Contingent Staffing PEAK Matrix. Its RPO unit, KellyOCG + Sevenstep, ranked No.1 in deal size and No.3 overall in HRO Today’s global RPO survey. Kelly is expanding in semiconductors, renewables, and advanced manufacturing. KELYA shares trade near $12–13, below analyst targets of $21–25.
16 October 2025

Stock Market Today

  • Thomson Reuters (TRI) Upgraded to Buy on Rising Earnings Estimates
    April 9, 2026, 2:13 PM EDT. Thomson Reuters (TRI) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates, a key factor influencing stock price movements. The Zacks rating, based solely on changes in earnings potential, signals an improved business outlook. This upgrade reflects growing confidence among institutional investors, who adjust share valuations based on earnings revisions, leading to potential stock price gains. The company is expected to earn $4.40 per share for the fiscal year ending December 2026, in line with last year. This upgrade highlights the importance of tracking earnings estimate revisions as a strategy for investment decisions in the near term.

Latest article

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

9 April 2026
The Dow Jones rose 247.66 points to 48,155.97 by midday Thursday, following a surge linked to signs of Middle East de-escalation and Israeli plans for peace talks with Lebanon. Oil prices fell over $4 a barrel after Netanyahu’s remarks, but remain 40% above pre-conflict levels. Amazon climbed 4.3% on strong AI revenue. Traders now see only a 30% chance of a Fed rate cut by year-end, down from 56%.
US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

9 April 2026
The Dow rose 337 points, or 0.7%, by 1 p.m. Thursday as oil prices retreated after Israel announced direct talks with Lebanon and hopes for a U.S.-Iran ceasefire steadied markets. Amazon shares climbed on news its AWS AI services topped $15 billion in annualized revenue. The Fed signaled possible rate hikes if inflation persists. Oil shipments through the Strait of Hormuz remained sharply reduced.
Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

9 April 2026
Amazon shares rose 5% Thursday after CEO Andy Jassy revealed AWS’s AI services are generating over $15 billion annually and its chip business more than $20 billion. Jassy said much of AWS’s $200 billion in planned 2026 spending is backed by customer commitments, including a $100 billion OpenAI deal. He also highlighted deep job cuts and a push for smaller teams. Amazon now operates over 1 million robots and plans to launch its Leo satellite network in mid-2026.
Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

9 April 2026
Unilever said Thursday it will acquire U.S. greens-supplement brand Grüns for an undisclosed sum, with the deal expected to close later this year pending approvals. Grüns was valued at about $500 million in a 2025 Series B round, according to Reuters. The purchase follows Unilever’s recent agreement to combine its food business with McCormick.
Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

9 April 2026
Lumentum shares climbed Thursday after JPMorgan raised its price target to $950, following Mizuho’s hike to $930. The moves come after Nvidia agreed last month to invest $2 billion in Lumentum and make multibillion-dollar purchase commitments. Lumentum reported February quarter revenue of $665.5 million, up 65.5% year-over-year. An SEC filing showed Lumentum will swap 5.7 million shares for $474.6 million in convertible notes.
Go toTop